IX Biopharma Ltd
SGX:42C
IX Biopharma Ltd
Revenue
IX Biopharma Ltd
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
I
|
IX Biopharma Ltd
SGX:42C
|
Revenue
S$6.1m
|
CAGR 3-Years
59%
|
CAGR 5-Years
75%
|
CAGR 10-Years
N/A
|
WAVE Life Sciences Ltd
NASDAQ:WVE
|
Revenue
$113.3m
|
CAGR 3-Years
78%
|
CAGR 5-Years
51%
|
CAGR 10-Years
N/A
|
|
Haw Par Corporation Ltd
SGX:H02
|
Revenue
S$232.1m
|
CAGR 3-Years
28%
|
CAGR 5-Years
0%
|
CAGR 10-Years
5%
|
|
H
|
Hyphens Pharma International Ltd
SGX:1J5
|
Revenue
S$170.6m
|
CAGR 3-Years
12%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
See Also
What is IX Biopharma Ltd's Revenue?
Revenue
6.1m
SGD
Based on the financial report for Dec 31, 2023, IX Biopharma Ltd's Revenue amounts to 6.1m SGD.
What is IX Biopharma Ltd's Revenue growth rate?
Revenue CAGR 5Y
75%
Over the last year, the Revenue growth was 62%. The average annual Revenue growth rates for IX Biopharma Ltd have been 59% over the past three years , 75% over the past five years .